This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Glioma
and you are
over 20
years old
-
The phase for this study is not defined.
Show me locations

The purpose

This is a study to assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and anti-tumor activity of DS-1001b in patients with gliomas that harbor IDH1-R132 mutations.

Provided treatments

  • Drug: DS-1001b

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03030066. The sponsor of the trial is Daiichi Sankyo Co., Ltd. and it is looking for 60 volunteers for the current phase.
Official trial title:
A Phase 1 Study of DS-1001b in Patients With IDH1 Mutated Gliomas